GrippeCanadaV4, Main, Exploration, bibRecord, 000103

Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.

Identifieur interne : 000103 ( Main/Exploration ); précédent : 000102; suivant : 000104

Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.

Auteurs : Danuta M. Skowronski [Canada] ; Catharine Chambers [Canada] ; Suzana Sabaiduc [Canada] ; James A. Dickinson [Canada] ; Anne-Luise Winter [Canada] ; Gaston De Serres [Canada] ; Steven J. Drews [Canada] ; Agatha Jassem [Canada] ; Jonathan B. Gubbay [Canada] ; Hugues Charest [Canada] ; Robert Balshaw [Canada] ; Nathalie Bastien [Canada] ; Yan Li [Canada] ; Mel Krajden [Canada]

Source :

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [ 1560-7917 ] ; 2017.

RBID : pubmed:28205503

Descripteurs français

KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Analyse de séquence d'ADN (MeSH), Canada (épidémiologie), Efficacité du vaccin (MeSH), Enfant (MeSH), Enfant d'âge préscolaire (MeSH), Femelle (MeSH), Grippe humaine (diagnostic), Grippe humaine (prévention et contrôle), Grippe humaine (virologie), Grippe humaine (épidémiologie), Humains (MeSH), Jeune adulte (MeSH), Nourrisson (MeSH), RT-PCR (MeSH), Saisons (MeSH), Sous-type H3N2 du virus de la grippe A (génétique), Sous-type H3N2 du virus de la grippe A (immunologie), Sous-type H3N2 du virus de la grippe A (isolement et purification), Sujet âgé (MeSH), Surveillance sentinelle (MeSH), Tests d'inhibition de l'hémagglutination (MeSH), Vaccination (statistiques et données numériques), Vaccins antigrippaux (administration et posologie), Vaccins antigrippaux (immunologie), Études cas-témoins (MeSH).
MESH :
- administration et posologie : Vaccins antigrippaux.
- diagnostic : Grippe humaine.
- génétique : Sous-type H3N2 du virus de la grippe A.
- immunologie : Sous-type H3N2 du virus de la grippe A, Vaccins antigrippaux.
- isolement et purification : Sous-type H3N2 du virus de la grippe A.
- prévention et contrôle : Grippe humaine.
- statistiques et données numériques : Vaccination.
- virologie : Grippe humaine.
- épidémiologie : Canada, Grippe humaine.
- Adolescent, Adulte, Adulte d'âge moyen, Analyse de séquence d'ADN, Efficacité du vaccin, Enfant, Enfant d'âge préscolaire, Femelle, Humains, Jeune adulte, Nourrisson, RT-PCR, Saisons, Sujet âgé, Surveillance sentinelle, Tests d'inhibition de l'hémagglutination, Études cas-témoins.
Wicri :
- geographic : Canada.

English descriptors

KwdEn :
- Adolescent (MeSH), Adult (MeSH), Aged (MeSH), Canada (epidemiology), Case-Control Studies (MeSH), Child (MeSH), Child, Preschool (MeSH), Female (MeSH), Hemagglutination Inhibition Tests (MeSH), Humans (MeSH), Infant (MeSH), Influenza A Virus, H3N2 Subtype (genetics), Influenza A Virus, H3N2 Subtype (immunology), Influenza A Virus, H3N2 Subtype (isolation & purification), Influenza Vaccines (administration & dosage), Influenza Vaccines (immunology), Influenza, Human (diagnosis), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Influenza, Human (virology), Middle Aged (MeSH), Outcome Assessment, Health Care (MeSH), Reverse Transcriptase Polymerase Chain Reaction (MeSH), Seasons (MeSH), Sentinel Surveillance (MeSH), Sequence Analysis, DNA (MeSH), Vaccination (statistics & numerical data), Vaccine Potency (MeSH), Young Adult (MeSH).
MESH :
- chemical , administration & dosage : Influenza Vaccines.
- geographic , epidemiology : Canada.
- diagnosis : Influenza, Human.
- epidemiology : Influenza, Human.
- genetics : Influenza A Virus, H3N2 Subtype.
- immunology : Influenza A Virus, H3N2 Subtype, Influenza Vaccines.
- isolation & purification : Influenza A Virus, H3N2 Subtype.
- prevention & control : Influenza, Human.
- statistics & numerical data : Vaccination.
- virology : Influenza, Human.
- Adolescent, Adult, Aged, Case-Control Studies, Child, Child, Preschool, Female, Hemagglutination Inhibition Tests, Humans, Infant, Middle Aged, Outcome Assessment, Health Care, Reverse Transcriptase Polymerase Chain Reaction, Seasons, Sentinel Surveillance, Sequence Analysis, DNA, Vaccine Potency, Young Adult.

Abstract

Using a test-negative design, the Canadian Sentinel Practitioner Surveillance Network (SPSN) assessed interim 2016/17 influenza vaccine effectiveness (VE) against dominant influenza A(H3N2) viruses considered antigenically matched to the clade 3C.2a vaccine strain. Sequence analysis revealed substantial heterogeneity in emerging 3C.2a1 variants by province and over time. Adjusted VE was 42% (95% confidence interval: 18-59%) overall, with variation by province. Interim virological and VE findings reported here warrant further investigation to inform potential vaccine reformulation.

DOI: 10.2807/1560-7917.ES.2017.22.6.30460
PubMed: 28205503
PubMed Central: PMC5316907

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000109
to stream Main, to step Curation: 000109

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.</title>
<author><name sortKey="Skowronski, Danuta M" sort="Skowronski, Danuta M" uniqKey="Skowronski D" first="Danuta M" last="Skowronski">Danuta M. Skowronski</name>
<affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>British Columbia Centre for Disease Control, Vancouver</wicri:regionArea>
<placeName><settlement type="city">Vancouver</settlement>
<region type="state">Colombie-Britannique</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>University of British Columbia, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of British Columbia, Vancouver</wicri:regionArea>
<placeName><settlement type="city">Vancouver</settlement>
<region type="state">Colombie-Britannique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chambers, Catharine" sort="Chambers, Catharine" uniqKey="Chambers C" first="Catharine" last="Chambers">Catharine Chambers</name>
<affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>British Columbia Centre for Disease Control, Vancouver</wicri:regionArea>
<placeName><settlement type="city">Vancouver</settlement>
<region type="state">Colombie-Britannique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sabaiduc, Suzana" sort="Sabaiduc, Suzana" uniqKey="Sabaiduc S" first="Suzana" last="Sabaiduc">Suzana Sabaiduc</name>
<affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>British Columbia Centre for Disease Control, Vancouver</wicri:regionArea>
<placeName><settlement type="city">Vancouver</settlement>
<region type="state">Colombie-Britannique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dickinson, James A" sort="Dickinson, James A" uniqKey="Dickinson J" first="James A" last="Dickinson">James A. Dickinson</name>
<affiliation wicri:level="4"><nlm:affiliation>University of Calgary, Calgary, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Calgary, Calgary</wicri:regionArea>
<placeName><settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
<orgName type="university">Université de Calgary</orgName>
</affiliation>
</author>
<author><name sortKey="Winter, Anne Luise" sort="Winter, Anne Luise" uniqKey="Winter A" first="Anne-Luise" last="Winter">Anne-Luise Winter</name>
<affiliation wicri:level="3"><nlm:affiliation>Public Health Ontario, Toronto, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Public Health Ontario, Toronto</wicri:regionArea>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="De Serres, Gaston" sort="De Serres, Gaston" uniqKey="De Serres G" first="Gaston" last="De Serres">Gaston De Serres</name>
<affiliation wicri:level="1"><nlm:affiliation>Institut National de Santé Publique du Québec (National Institute of Health of Quebec), Québec, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Institut National de Santé Publique du Québec (National Institute of Health of Quebec), Québec</wicri:regionArea>
<wicri:noRegion>Québec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>Laval University, Quebec, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Laval University, Quebec</wicri:regionArea>
<orgName type="university">Université Laval</orgName>
<placeName><settlement type="city">Québec (ville)</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Centre Hospitalier Universitaire de Québec (University Hospital Centre of Quebec), Québec, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Centre Hospitalier Universitaire de Québec (University Hospital Centre of Quebec), Québec</wicri:regionArea>
<wicri:noRegion>Québec</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Drews, Steven J" sort="Drews, Steven J" uniqKey="Drews S" first="Steven J" last="Drews">Steven J. Drews</name>
<affiliation wicri:level="3"><nlm:affiliation>Alberta Provincial Laboratory, Edmonton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Alberta Provincial Laboratory, Edmonton</wicri:regionArea>
<placeName><settlement type="city">Edmonton</settlement>
<region type="state">Alberta</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>University of Alberta, Edmonton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Alberta, Edmonton</wicri:regionArea>
<placeName><settlement type="city">Edmonton</settlement>
<region type="state">Alberta</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jassem, Agatha" sort="Jassem, Agatha" uniqKey="Jassem A" first="Agatha" last="Jassem">Agatha Jassem</name>
<affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>British Columbia Centre for Disease Control, Vancouver</wicri:regionArea>
<placeName><settlement type="city">Vancouver</settlement>
<region type="state">Colombie-Britannique</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>University of British Columbia, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of British Columbia, Vancouver</wicri:regionArea>
<placeName><settlement type="city">Vancouver</settlement>
<region type="state">Colombie-Britannique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gubbay, Jonathan B" sort="Gubbay, Jonathan B" uniqKey="Gubbay J" first="Jonathan B" last="Gubbay">Jonathan B. Gubbay</name>
<affiliation wicri:level="3"><nlm:affiliation>Public Health Ontario, Toronto, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Public Health Ontario, Toronto</wicri:regionArea>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>University of Toronto, Toronto, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Toronto, Toronto</wicri:regionArea>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Charest, Hugues" sort="Charest, Hugues" uniqKey="Charest H" first="Hugues" last="Charest">Hugues Charest</name>
<affiliation wicri:level="1"><nlm:affiliation>Institut National de Santé Publique du Québec (National Institute of Health of Quebec), Québec, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Institut National de Santé Publique du Québec (National Institute of Health of Quebec), Québec</wicri:regionArea>
<wicri:noRegion>Québec</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Balshaw, Robert" sort="Balshaw, Robert" uniqKey="Balshaw R" first="Robert" last="Balshaw">Robert Balshaw</name>
<affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>British Columbia Centre for Disease Control, Vancouver</wicri:regionArea>
<placeName><settlement type="city">Vancouver</settlement>
<region type="state">Colombie-Britannique</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>University of British Columbia, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of British Columbia, Vancouver</wicri:regionArea>
<placeName><settlement type="city">Vancouver</settlement>
<region type="state">Colombie-Britannique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bastien, Nathalie" sort="Bastien, Nathalie" uniqKey="Bastien N" first="Nathalie" last="Bastien">Nathalie Bastien</name>
<affiliation wicri:level="1"><nlm:affiliation>National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg</wicri:regionArea>
<wicri:noRegion>Winnipeg</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Li, Yan" sort="Li, Yan" uniqKey="Li Y" first="Yan" last="Li">Yan Li</name>
<affiliation wicri:level="1"><nlm:affiliation>National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg</wicri:regionArea>
<wicri:noRegion>Winnipeg</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Krajden, Mel" sort="Krajden, Mel" uniqKey="Krajden M" first="Mel" last="Krajden">Mel Krajden</name>
<affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>British Columbia Centre for Disease Control, Vancouver</wicri:regionArea>
<placeName><settlement type="city">Vancouver</settlement>
<region type="state">Colombie-Britannique</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>University of British Columbia, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of British Columbia, Vancouver</wicri:regionArea>
<placeName><settlement type="city">Vancouver</settlement>
<region type="state">Colombie-Britannique</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28205503</idno>
<idno type="pmid">28205503</idno>
<idno type="doi">10.2807/1560-7917.ES.2017.22.6.30460</idno>
<idno type="pmc">PMC5316907</idno>
<idno type="wicri:Area/Main/Corpus">000109</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000109</idno>
<idno type="wicri:Area/Main/Curation">000109</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000109</idno>
<idno type="wicri:Area/Main/Exploration">000109</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.</title>
<author><name sortKey="Skowronski, Danuta M" sort="Skowronski, Danuta M" uniqKey="Skowronski D" first="Danuta M" last="Skowronski">Danuta M. Skowronski</name>
<affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>British Columbia Centre for Disease Control, Vancouver</wicri:regionArea>
<placeName><settlement type="city">Vancouver</settlement>
<region type="state">Colombie-Britannique</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>University of British Columbia, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of British Columbia, Vancouver</wicri:regionArea>
<placeName><settlement type="city">Vancouver</settlement>
<region type="state">Colombie-Britannique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chambers, Catharine" sort="Chambers, Catharine" uniqKey="Chambers C" first="Catharine" last="Chambers">Catharine Chambers</name>
<affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>British Columbia Centre for Disease Control, Vancouver</wicri:regionArea>
<placeName><settlement type="city">Vancouver</settlement>
<region type="state">Colombie-Britannique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sabaiduc, Suzana" sort="Sabaiduc, Suzana" uniqKey="Sabaiduc S" first="Suzana" last="Sabaiduc">Suzana Sabaiduc</name>
<affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>British Columbia Centre for Disease Control, Vancouver</wicri:regionArea>
<placeName><settlement type="city">Vancouver</settlement>
<region type="state">Colombie-Britannique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dickinson, James A" sort="Dickinson, James A" uniqKey="Dickinson J" first="James A" last="Dickinson">James A. Dickinson</name>
<affiliation wicri:level="4"><nlm:affiliation>University of Calgary, Calgary, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Calgary, Calgary</wicri:regionArea>
<placeName><settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
<orgName type="university">Université de Calgary</orgName>
</affiliation>
</author>
<author><name sortKey="Winter, Anne Luise" sort="Winter, Anne Luise" uniqKey="Winter A" first="Anne-Luise" last="Winter">Anne-Luise Winter</name>
<affiliation wicri:level="3"><nlm:affiliation>Public Health Ontario, Toronto, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Public Health Ontario, Toronto</wicri:regionArea>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="De Serres, Gaston" sort="De Serres, Gaston" uniqKey="De Serres G" first="Gaston" last="De Serres">Gaston De Serres</name>
<affiliation wicri:level="1"><nlm:affiliation>Institut National de Santé Publique du Québec (National Institute of Health of Quebec), Québec, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Institut National de Santé Publique du Québec (National Institute of Health of Quebec), Québec</wicri:regionArea>
<wicri:noRegion>Québec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>Laval University, Quebec, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Laval University, Quebec</wicri:regionArea>
<orgName type="university">Université Laval</orgName>
<placeName><settlement type="city">Québec (ville)</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Centre Hospitalier Universitaire de Québec (University Hospital Centre of Quebec), Québec, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Centre Hospitalier Universitaire de Québec (University Hospital Centre of Quebec), Québec</wicri:regionArea>
<wicri:noRegion>Québec</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Drews, Steven J" sort="Drews, Steven J" uniqKey="Drews S" first="Steven J" last="Drews">Steven J. Drews</name>
<affiliation wicri:level="3"><nlm:affiliation>Alberta Provincial Laboratory, Edmonton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Alberta Provincial Laboratory, Edmonton</wicri:regionArea>
<placeName><settlement type="city">Edmonton</settlement>
<region type="state">Alberta</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>University of Alberta, Edmonton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Alberta, Edmonton</wicri:regionArea>
<placeName><settlement type="city">Edmonton</settlement>
<region type="state">Alberta</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jassem, Agatha" sort="Jassem, Agatha" uniqKey="Jassem A" first="Agatha" last="Jassem">Agatha Jassem</name>
<affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>British Columbia Centre for Disease Control, Vancouver</wicri:regionArea>
<placeName><settlement type="city">Vancouver</settlement>
<region type="state">Colombie-Britannique</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>University of British Columbia, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of British Columbia, Vancouver</wicri:regionArea>
<placeName><settlement type="city">Vancouver</settlement>
<region type="state">Colombie-Britannique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gubbay, Jonathan B" sort="Gubbay, Jonathan B" uniqKey="Gubbay J" first="Jonathan B" last="Gubbay">Jonathan B. Gubbay</name>
<affiliation wicri:level="3"><nlm:affiliation>Public Health Ontario, Toronto, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Public Health Ontario, Toronto</wicri:regionArea>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>University of Toronto, Toronto, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Toronto, Toronto</wicri:regionArea>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Charest, Hugues" sort="Charest, Hugues" uniqKey="Charest H" first="Hugues" last="Charest">Hugues Charest</name>
<affiliation wicri:level="1"><nlm:affiliation>Institut National de Santé Publique du Québec (National Institute of Health of Quebec), Québec, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Institut National de Santé Publique du Québec (National Institute of Health of Quebec), Québec</wicri:regionArea>
<wicri:noRegion>Québec</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Balshaw, Robert" sort="Balshaw, Robert" uniqKey="Balshaw R" first="Robert" last="Balshaw">Robert Balshaw</name>
<affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>British Columbia Centre for Disease Control, Vancouver</wicri:regionArea>
<placeName><settlement type="city">Vancouver</settlement>
<region type="state">Colombie-Britannique</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>University of British Columbia, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of British Columbia, Vancouver</wicri:regionArea>
<placeName><settlement type="city">Vancouver</settlement>
<region type="state">Colombie-Britannique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bastien, Nathalie" sort="Bastien, Nathalie" uniqKey="Bastien N" first="Nathalie" last="Bastien">Nathalie Bastien</name>
<affiliation wicri:level="1"><nlm:affiliation>National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg</wicri:regionArea>
<wicri:noRegion>Winnipeg</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Li, Yan" sort="Li, Yan" uniqKey="Li Y" first="Yan" last="Li">Yan Li</name>
<affiliation wicri:level="1"><nlm:affiliation>National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg</wicri:regionArea>
<wicri:noRegion>Winnipeg</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Krajden, Mel" sort="Krajden, Mel" uniqKey="Krajden M" first="Mel" last="Krajden">Mel Krajden</name>
<affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>British Columbia Centre for Disease Control, Vancouver</wicri:regionArea>
<placeName><settlement type="city">Vancouver</settlement>
<region type="state">Colombie-Britannique</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>University of British Columbia, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of British Columbia, Vancouver</wicri:regionArea>
<placeName><settlement type="city">Vancouver</settlement>
<region type="state">Colombie-Britannique</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</title>
<idno type="eISSN">1560-7917</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Canada (epidemiology)</term>
<term>Case-Control Studies (MeSH)</term>
<term>Child (MeSH)</term>
<term>Child, Preschool (MeSH)</term>
<term>Female (MeSH)</term>
<term>Hemagglutination Inhibition Tests (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Infant (MeSH)</term>
<term>Influenza A Virus, H3N2 Subtype (genetics)</term>
<term>Influenza A Virus, H3N2 Subtype (immunology)</term>
<term>Influenza A Virus, H3N2 Subtype (isolation & purification)</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Influenza, Human (diagnosis)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Influenza, Human (virology)</term>
<term>Middle Aged (MeSH)</term>
<term>Outcome Assessment, Health Care (MeSH)</term>
<term>Reverse Transcriptase Polymerase Chain Reaction (MeSH)</term>
<term>Seasons (MeSH)</term>
<term>Sentinel Surveillance (MeSH)</term>
<term>Sequence Analysis, DNA (MeSH)</term>
<term>Vaccination (statistics & numerical data)</term>
<term>Vaccine Potency (MeSH)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Analyse de séquence d'ADN (MeSH)</term>
<term>Canada (épidémiologie)</term>
<term>Efficacité du vaccin (MeSH)</term>
<term>Enfant (MeSH)</term>
<term>Enfant d'âge préscolaire (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Grippe humaine (diagnostic)</term>
<term>Grippe humaine (prévention et contrôle)</term>
<term>Grippe humaine (virologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains (MeSH)</term>
<term>Jeune adulte (MeSH)</term>
<term>Nourrisson (MeSH)</term>
<term>RT-PCR (MeSH)</term>
<term>Saisons (MeSH)</term>
<term>Sous-type H3N2 du virus de la grippe A (génétique)</term>
<term>Sous-type H3N2 du virus de la grippe A (immunologie)</term>
<term>Sous-type H3N2 du virus de la grippe A (isolement et purification)</term>
<term>Sujet âgé (MeSH)</term>
<term>Surveillance sentinelle (MeSH)</term>
<term>Tests d'inhibition de l'hémagglutination (MeSH)</term>
<term>Vaccination (statistiques et données numériques)</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>Études cas-témoins (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Canada</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Influenza A Virus, H3N2 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Sous-type H3N2 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Sous-type H3N2 du virus de la grippe A</term>
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H3N2 Subtype</term>
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Influenza A Virus, H3N2 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Sous-type H3N2 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Canada</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Case-Control Studies</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Hemagglutination Inhibition Tests</term>
<term>Humans</term>
<term>Infant</term>
<term>Middle Aged</term>
<term>Outcome Assessment, Health Care</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
<term>Seasons</term>
<term>Sentinel Surveillance</term>
<term>Sequence Analysis, DNA</term>
<term>Vaccine Potency</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse de séquence d'ADN</term>
<term>Efficacité du vaccin</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Nourrisson</term>
<term>RT-PCR</term>
<term>Saisons</term>
<term>Sujet âgé</term>
<term>Surveillance sentinelle</term>
<term>Tests d'inhibition de l'hémagglutination</term>
<term>Études cas-témoins</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Using a test-negative design, the Canadian Sentinel Practitioner Surveillance Network (SPSN) assessed interim 2016/17 influenza vaccine effectiveness (VE) against dominant influenza A(H3N2) viruses considered antigenically matched to the clade 3C.2a vaccine strain. Sequence analysis revealed substantial heterogeneity in emerging 3C.2a1 variants by province and over time. Adjusted VE was 42% (95% confidence interval: 18-59%) overall, with variation by province. Interim virological and VE findings reported here warrant further investigation to inform potential vaccine reformulation.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28205503</PMID>
<DateCompleted><Year>2017</Year>
<Month>05</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1560-7917</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>22</Volume>
<Issue>6</Issue>
<PubDate><Year>2017</Year>
<Month>Feb</Month>
<Day>09</Day>
</PubDate>
</JournalIssue>
<Title>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</Title>
<ISOAbbreviation>Euro Surveill.</ISOAbbreviation>
</Journal>
<ArticleTitle>Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.2807/1560-7917.ES.2017.22.6.30460</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">30460</ELocationID>
<Abstract><AbstractText>Using a test-negative design, the Canadian Sentinel Practitioner Surveillance Network (SPSN) assessed interim 2016/17 influenza vaccine effectiveness (VE) against dominant influenza A(H3N2) viruses considered antigenically matched to the clade 3C.2a vaccine strain. Sequence analysis revealed substantial heterogeneity in emerging 3C.2a1 variants by province and over time. Adjusted VE was 42% (95% confidence interval: 18-59%) overall, with variation by province. Interim virological and VE findings reported here warrant further investigation to inform potential vaccine reformulation.</AbstractText>
<CopyrightInformation>This article is copyright of The Authors, 2017.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Skowronski</LastName>
<ForeName>Danuta M</ForeName>
<Initials>DM</Initials>
<AffiliationInfo><Affiliation>British Columbia Centre for Disease Control, Vancouver, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>University of British Columbia, Vancouver, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chambers</LastName>
<ForeName>Catharine</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>British Columbia Centre for Disease Control, Vancouver, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sabaiduc</LastName>
<ForeName>Suzana</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>British Columbia Centre for Disease Control, Vancouver, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Dickinson</LastName>
<ForeName>James A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo><Affiliation>University of Calgary, Calgary, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Winter</LastName>
<ForeName>Anne-Luise</ForeName>
<Initials>AL</Initials>
<AffiliationInfo><Affiliation>Public Health Ontario, Toronto, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>De Serres</LastName>
<ForeName>Gaston</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Institut National de Santé Publique du Québec (National Institute of Health of Quebec), Québec, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Laval University, Quebec, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Centre Hospitalier Universitaire de Québec (University Hospital Centre of Quebec), Québec, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Drews</LastName>
<ForeName>Steven J</ForeName>
<Initials>SJ</Initials>
<AffiliationInfo><Affiliation>Alberta Provincial Laboratory, Edmonton, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>University of Alberta, Edmonton, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jassem</LastName>
<ForeName>Agatha</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>British Columbia Centre for Disease Control, Vancouver, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>University of British Columbia, Vancouver, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gubbay</LastName>
<ForeName>Jonathan B</ForeName>
<Initials>JB</Initials>
<AffiliationInfo><Affiliation>Public Health Ontario, Toronto, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>University of Toronto, Toronto, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Charest</LastName>
<ForeName>Hugues</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Institut National de Santé Publique du Québec (National Institute of Health of Quebec), Québec, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Balshaw</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>British Columbia Centre for Disease Control, Vancouver, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>University of British Columbia, Vancouver, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bastien</LastName>
<ForeName>Nathalie</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Li</LastName>
<ForeName>Yan</ForeName>
<Initials>Y</Initials>
<AffiliationInfo><Affiliation>National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Krajden</LastName>
<ForeName>Mel</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>British Columbia Centre for Disease Control, Vancouver, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>University of British Columbia, Vancouver, Canada.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Sweden</Country>
<MedlineTA>Euro Surveill</MedlineTA>
<NlmUniqueID>100887452</NlmUniqueID>
<ISSNLinking>1025-496X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006385" MajorTopicYN="N">Hemagglutination Inhibition Tests</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053122" MajorTopicYN="N">Influenza A Virus, H3N2 Subtype</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018571" MajorTopicYN="N">Sentinel Surveillance</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D064166" MajorTopicYN="Y">Vaccine Potency</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">effectiveness</Keyword>
<Keyword MajorTopicYN="N">influenza</Keyword>
<Keyword MajorTopicYN="N">influenza virus</Keyword>
<Keyword MajorTopicYN="N">influenza-like illness - ILI</Keyword>
<Keyword MajorTopicYN="N">vaccine-preventable diseases</Keyword>
<Keyword MajorTopicYN="N">vaccines and immunisation</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year>
<Month>02</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2017</Year>
<Month>02</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2017</Year>
<Month>2</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2017</Year>
<Month>2</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>5</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">28205503</ArticleId>
<ArticleId IdType="doi">10.2807/1560-7917.ES.2017.22.6.30460</ArticleId>
<ArticleId IdType="pii">30460</ArticleId>
<ArticleId IdType="pmc">PMC5316907</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Euro Surveill. 2015 Jan 29;20(4):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25655053</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14001-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10570188</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2016 Aug;16(8):942-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27061888</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Viruses. 2014 Mar 14;6(3):1294-316</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24638204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2016;21(3):30112</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26836031</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Bioinformatics. 2015 Nov 1;31(21):3546-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26115986</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2012;7(7):e41895</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22848649</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Epidemiol. 2007 Jun;36(3):623-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17403908</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Sep;78(18):9605-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15331693</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Proteome Res. 2015 Sep 4;14(9):3957-69</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26202417</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2013 Nov 22;342(6161):976-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24264991</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2009 May 26;106(21):8701-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19439657</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2009 Jun 18;360(25):2605-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19423869</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2013 Nov 27;8(11):e80481</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24312225</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2016 Jul 1;63(1):21-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27025838</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2011 Apr;49(4):1653-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21270233</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2016 Apr 21;21(16):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27124573</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2003 Jan 8;289(2):179-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12517228</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Canada</li>
</country>
<region><li>Alberta</li>
<li>Colombie-Britannique</li>
<li>Ontario</li>
<li>Québec</li>
</region>
<settlement><li>Calgary</li>
<li>Edmonton</li>
<li>Québec (ville)</li>
<li>Toronto</li>
<li>Vancouver</li>
</settlement>
<orgName><li>Université Laval</li>
<li>Université de Calgary</li>
<li>Université de Toronto</li>
</orgName>
</list>
<tree><country name="Canada"><region name="Colombie-Britannique"><name sortKey="Skowronski, Danuta M" sort="Skowronski, Danuta M" uniqKey="Skowronski D" first="Danuta M" last="Skowronski">Danuta M. Skowronski</name>
</region>
<name sortKey="Balshaw, Robert" sort="Balshaw, Robert" uniqKey="Balshaw R" first="Robert" last="Balshaw">Robert Balshaw</name>
<name sortKey="Balshaw, Robert" sort="Balshaw, Robert" uniqKey="Balshaw R" first="Robert" last="Balshaw">Robert Balshaw</name>
<name sortKey="Bastien, Nathalie" sort="Bastien, Nathalie" uniqKey="Bastien N" first="Nathalie" last="Bastien">Nathalie Bastien</name>
<name sortKey="Chambers, Catharine" sort="Chambers, Catharine" uniqKey="Chambers C" first="Catharine" last="Chambers">Catharine Chambers</name>
<name sortKey="Charest, Hugues" sort="Charest, Hugues" uniqKey="Charest H" first="Hugues" last="Charest">Hugues Charest</name>
<name sortKey="De Serres, Gaston" sort="De Serres, Gaston" uniqKey="De Serres G" first="Gaston" last="De Serres">Gaston De Serres</name>
<name sortKey="De Serres, Gaston" sort="De Serres, Gaston" uniqKey="De Serres G" first="Gaston" last="De Serres">Gaston De Serres</name>
<name sortKey="De Serres, Gaston" sort="De Serres, Gaston" uniqKey="De Serres G" first="Gaston" last="De Serres">Gaston De Serres</name>
<name sortKey="Dickinson, James A" sort="Dickinson, James A" uniqKey="Dickinson J" first="James A" last="Dickinson">James A. Dickinson</name>
<name sortKey="Drews, Steven J" sort="Drews, Steven J" uniqKey="Drews S" first="Steven J" last="Drews">Steven J. Drews</name>
<name sortKey="Drews, Steven J" sort="Drews, Steven J" uniqKey="Drews S" first="Steven J" last="Drews">Steven J. Drews</name>
<name sortKey="Gubbay, Jonathan B" sort="Gubbay, Jonathan B" uniqKey="Gubbay J" first="Jonathan B" last="Gubbay">Jonathan B. Gubbay</name>
<name sortKey="Gubbay, Jonathan B" sort="Gubbay, Jonathan B" uniqKey="Gubbay J" first="Jonathan B" last="Gubbay">Jonathan B. Gubbay</name>
<name sortKey="Jassem, Agatha" sort="Jassem, Agatha" uniqKey="Jassem A" first="Agatha" last="Jassem">Agatha Jassem</name>
<name sortKey="Jassem, Agatha" sort="Jassem, Agatha" uniqKey="Jassem A" first="Agatha" last="Jassem">Agatha Jassem</name>
<name sortKey="Krajden, Mel" sort="Krajden, Mel" uniqKey="Krajden M" first="Mel" last="Krajden">Mel Krajden</name>
<name sortKey="Krajden, Mel" sort="Krajden, Mel" uniqKey="Krajden M" first="Mel" last="Krajden">Mel Krajden</name>
<name sortKey="Li, Yan" sort="Li, Yan" uniqKey="Li Y" first="Yan" last="Li">Yan Li</name>
<name sortKey="Sabaiduc, Suzana" sort="Sabaiduc, Suzana" uniqKey="Sabaiduc S" first="Suzana" last="Sabaiduc">Suzana Sabaiduc</name>
<name sortKey="Skowronski, Danuta M" sort="Skowronski, Danuta M" uniqKey="Skowronski D" first="Danuta M" last="Skowronski">Danuta M. Skowronski</name>
<name sortKey="Winter, Anne Luise" sort="Winter, Anne Luise" uniqKey="Winter A" first="Anne-Luise" last="Winter">Anne-Luise Winter</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeCanadaV4/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000103 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000103 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeCanadaV4
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:28205503
   |texte=   Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:28205503" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeCanadaV4

This area was generated with Dilib version V0.6.35.
Data generation: Sat Aug 8 18:52:12 2020. Site generation: Sat Feb 13 16:40:04 2021

	Serveur d'exploration sur la grippe au Canada
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la grippe au Canada

Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.

Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki